These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16408859)

  • 1. Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension.
    Dayal P; Pillay V; Babu RJ; Singh M
    AAPS PharmSciTech; 2005 Nov; 6(4):E573-85. PubMed ID: 16408859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design.
    Guo C; Stine KJ; Kauffman JF; Doub WH
    Eur J Pharm Sci; 2008 Dec; 35(5):417-26. PubMed ID: 18832029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.
    Dayal P; Shaik MS; Singh M
    J Pharm Sci; 2004 Jul; 93(7):1725-42. PubMed ID: 15176062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery.
    Young PM; Traini D; Ong HX; Granieri A; Zhu B; Scalia S; Song J; Spicer PT
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1729-1733. PubMed ID: 28581833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA).
    Liu X; Doub WH; Guo C
    AAPS PharmSciTech; 2011 Mar; 12(1):337-43. PubMed ID: 21286880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of Formulation and Delivery Device-Related Effects on In Vitro Performance of Nasal Spray with Implication to Rational Product Specification Identification.
    Grmaš J; Stare K; Božič D; Injac R; Dreu R
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):230-246. PubMed ID: 28075184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
    Gajra B; Patel RR; Dalwadi C
    Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
    Pitta SK; Dudhipala N; Narala A; Veerabrahma K
    Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.
    Zhu S; Hong M; Liu C; Pei Y
    Pharm Dev Technol; 2009; 14(6):642-9. PubMed ID: 19883253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development of sustained-release hydrophilic matrix tablets of zileuton.
    Qiu Y; Hui HW; Cheskin H
    Pharm Dev Technol; 1997 Aug; 2(3):197-204. PubMed ID: 9552447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Box-Behnken experimental design for preparation and optimization of the intranasal gels of selegiline hydrochloride.
    Salatin S; Alami-Milani M; Daneshgar R; Jelvehgari M
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1613-1621. PubMed ID: 29932793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the vibrating membrane aerosol generation device: Aeroneb Micropump Nebulizer.
    Zhang G; David A; Wiedmann TS
    J Aerosol Med; 2007; 20(4):408-16. PubMed ID: 18158713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of laser diffraction measurements by Mastersizer X and Spraytec to characterize droplet size distribution of medical liquid aerosols.
    Lelong N; Junqua-Moullet A; Diot P; Vecellio L
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):94-102. PubMed ID: 23668547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of actuation parameters on in vitro testing of nasal spray products.
    Guo C; Doub WH
    J Pharm Sci; 2006 Sep; 95(9):2029-40. PubMed ID: 16865693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of mucoadhesive sprayable gellan gum fluid gels.
    Mahdi MH; Conway BR; Smith AM
    Int J Pharm; 2015 Jul; 488(1-2):12-9. PubMed ID: 25863119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery.
    Beck-Broichsitter M; Oesterheld N; Knuedeler MC; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 461(1-2):34-7. PubMed ID: 24291081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of magnetizable aerosols.
    Baumann R; Glöckl G; Nagel S; Weitschies W
    Eur J Pharm Sci; 2012 Apr; 45(5):693-7. PubMed ID: 22306649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
    Galgatte UC; Kumbhar AB; Chaudhari PD
    Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.